U.S. Capital Markets Stock News

Core Molding Technologies (CMT) is aiming for a massive 46.5% annual EPS growth rate over the next three years, which easily outpaces the US market average of 16%. This outlook comes as the company posts a forecasted 6.4% revenue growth per year, lagging the US market’s 10.5% average, and a net profit margin of 3.1%, down from 4.9% a year ago. After growing earnings at 20.7% per year over the last five years, CMT enters this period with a high-quality earnings track record but faces margin...

Taysha Gene Therapies (TSHA) remains unprofitable, but its revenue is forecast to grow rapidly by 70.5% per year, far outpacing the broader US market's expected 10.5% annual growth. Over the past five years, the company has managed to cut its losses at a 7.5% annual rate, even as it is projected to stay in the red for at least the next three years. With shares recently trading at $4.27, below an estimated fair value of $20.71, investors are weighing the promise of significant top-line growth...

Portillo’s (PTLO) is forecast to grow revenue at 8.5% per year, which trails the broader US market’s pace of 10.5%. Despite this, the company’s earnings are expected to climb 16.9% per year, a notch above the market’s 16% average, while net profit margins edged down to 3.4% from last year’s 3.6%. Investors are watching this mix of slower sales growth but faster earnings momentum, especially as the company maintains modest profitability and a valuation that sits between direct peers and the...

Leidos Holdings (LDOS) posted 16.9% earnings growth for the past year, outpacing its five-year average of 13.7% per year. Net profit margin also improved to 8.1% from last year’s 7.4%, while management continues to deliver high-quality results. Looking ahead, consensus expects earnings to increase by 3.5% per year and revenue by 2.7%, both trailing the broader U.S. market averages. See our full analysis for Leidos Holdings. Next, we will see how these headline numbers compare to the current...

Castle Biosciences (CSTL) continues to operate at a loss, with recent filings confirming the company has yet to achieve net profit margin improvement over the past year and is still generating negative earnings. Despite reducing its annual losses at a rate of 9.6% per year over the last five years, it remains on a slower growth path. Forecasted revenue is expected to rise 6.5% per year, lagging behind the broader US market’s 10.5% annual growth rate. With profitability still out of reach in...

Rhythm Pharmaceuticals (RYTM) reported widening losses, with net losses having grown at a rate of 18.8% per year over the past five years. Despite being unprofitable, the company commands a Price-To-Sales Ratio of 40x, outpacing both the US Biotechs industry average of 10.8x and the peer average of 17.9x, positioning its stock as highly valued on these multiples. On the growth front, forecasts point to revenue expanding at 45.8% per year and earnings projected to grow 70.56% per year, with...

PRA Group (PRAA) is currently unprofitable, with losses having grown at an average annual rate of 48.8% over the last five years. While revenue is projected to grow at 6.6% per year, this is slower than the broader US market’s pace of 10.5% per year. The company is expected to remain unprofitable for at least the next three years. Margins have seen no improvement over the past year, signaling that profitability remains a persistent challenge for investors considering this stock. See our full...

Ormat Technologies (ORA) posted net profit margins of 14.1%, up from last year’s 13.3%, and delivered 16.7% average annual earnings growth over the past five years. However, the latest year’s earnings growth was 12.4%, trailing both the company’s own historical average and the projected pace of 8.1% earnings and 8.6% revenue growth going forward. Both figures are below the US market’s forecasted profit and revenue growth rates of 16% and 10.5%. These results come as the stock trades at a...

BWX Technologies (NYSE:BWXT) is expected to deliver annual earnings growth of 10.8% and revenue growth of 8.7%. These rates trail the broader US market averages of 16% and 10.5%, respectively. Net profit margins sit at 10%, marking a slight dip from last year’s 10.3%. Notably, the company’s earnings have jumped 10.9% over the past year compared to a five-year average of just 0.2% per year. With the stock trading well above the fair value estimate and at a price-to-earnings ratio higher than...

Apple Hospitality REIT (APLE) delivered mixed results in its latest earnings, with a notable reversal in momentum from previous years. Net profit margins declined to 12.4% compared to last year’s 14.5%, and the company posted negative earnings growth over the past twelve months after growing earnings by 49.5% annually over the last five years. Looking ahead, management expects revenue to rise just 1.8% per year and earnings to grow at 0.7%, both lagging the broader US market. This may weigh...

Douglas Dynamics (PLOW) posted a net profit margin of 6.6%, down from 9.7% last year, ending a five-year run of strong profitability gains that saw average annual earnings growth of 45.8%. Revenue is projected to rise by 6.5% annually, trailing the broader US market's 10.5% pace. Expected EPS growth of 14.7% also lags behind the 16% market forecast. Investors are likely to view these results as a sign of recent margin pressure. However, with shares trading below fair value and analyst...

PotlatchDeltic (PCH) delivered a sharp turnaround in profitability this quarter, with its net profit margin climbing to 5.8%, up from just 1.6% a year ago, and earnings rising 288.4% year-over-year. This is far stronger than its five-year average, which saw earnings declining 38.9% per year. Looking ahead, the company is forecasting annual earnings growth of 17.9%, set to outpace the broader US market, while management values shares below their estimated fair value at $38.95. These improving...

ThredUp (TDUP) remains unprofitable, but revenue is forecast to grow at 10.8% per year, while losses have narrowed by 14.8% annually over the past five years. With a Price-to-Sales Ratio of 3.4x, the stock trades well above the US Specialty Retail industry average of 0.4x and the peer average of 1.1x. While margins are still negative, ongoing top-line growth combined with improving losses gives investors reasons to keep an eye on the company’s progress. See our full analysis for ThredUp. Now...

Boise Cascade (BCC) reported annual earnings growth of 17.5%, outpacing the broader US market forecast of 16%. However, revenue is projected to grow at just 3.3% per year, trailing the US average of 10.5%. Net profit margins declined to 3%, down from 6% the previous year. The company has seen average annual earnings decrease by 6.3% over the last five years. Despite the recent dip in profitability and ongoing margin compression, analysts expect stronger profit growth ahead, and BCC currently...

JELD-WEN Holding (JELD) posted another unprofitable quarter, with both its earnings and net profit margin remaining in the red. Over the last five years, losses have widened at a staggering 78.1% per year. The company is projected to swing to profitability within the next three years as earnings are forecast to surge 131.26% per year. Despite slow anticipated revenue growth of just 1.9% annually, the stock trades at a price-to-sales multiple of just 0.1x, far lower than industry and peer...

Atlas Energy Solutions (AESI) remains unprofitable, but it has narrowed its losses by 2.7% per year over the past five years. While margins have yet to turn positive and fresh figures on recent profitability are not available, earnings are forecast to surge by 110.88% annually. This may put the company on track for potential profitability within three years, which is well ahead of market averages. With revenue expected to grow at only 2.2% per year compared to the broader US market's 10.5%,...

Federal Agricultural Mortgage (AGM) posted net profit margins of 50.9%, edging up from last year’s 49%. Over the past five years, AGM has averaged 14.2% annual earnings growth, and most recently, earnings climbed 13.1%. Looking ahead, earnings are projected to rise about 8% per year, a pace that trails the wider US market's expected 16% annual growth. Revenue growth is anticipated to slightly outperform at 10.8% per year compared to the US market’s 10.5%. See our full analysis for Federal...

James River Group Holdings (JRVR) posted a continued loss, with the company’s losses increasing at an average rate of 2.3% per year over the past five years. Looking ahead, analysts expect earnings to rebound sharply and are forecasting annual growth of 88.79% with a return to profitability within three years. With relative value compared to peers and the prospect of rapid earnings improvement, investors may see reasons for optimism despite a challenging recent track record. See our full...

Super Group (SGHC) posted a striking surge in net profit margins, coming in at 9.8% compared to just 0.3% last year. This improvement was fueled by an extraordinary 4,994.9% earnings growth over the same period. Looking ahead, the company’s earnings are expected to grow 32.2% per year, far outpacing the broader US market’s forecast of 16% per year. Revenue is projected to rise by 9.2% annually, just below the US average of 10.5%. With these numbers, investors are seeing a notable turnaround...

Voyager Technologies (VOYG) remains unprofitable, with no established year-on-year earnings trend so far, as the company has been publicly traded for less than three years. Revenue is forecast to surge 51.5% per year, far outpacing the US market average of 10.5%. However, net margins remain negative and the Price-To-Sales Ratio sits at a steep 10.3x, well above industry and peer benchmarks. With investors focused on whether overhead and costs are being effectively controlled, the company’s...

Addus HomeCare (ADUS) delivered earnings growth of 16.3% over the past year, with a robust five-year compound annual growth rate for earnings of 19.4%. Earnings are forecast to keep climbing at 16.4% per year, outpacing the broader US market average forecast, while net profit margins held steady at 6.4% compared to 6.5% a year ago. Although revenue growth is set to lag the wider market at 7.8% annually, the company’s consistent track record of profitability and favorable valuation relative to...

Syndax Pharmaceuticals (SNDX) remains unprofitable as net losses have widened at 41.3% per year over the past five years. Net profit margins have stayed negative with no track record of high-quality earnings. Looking forward, revenue is forecast to climb 40.4% annually, outpacing the US market. Earnings are projected to surge 72.8% per year with profitability expected within three years. The share price has settled at $15.35, notably below its estimated fair value of $214.76. The company...

Vornado Realty Trust (VNO) has turned profitable, posting a robust 46.1% per year earnings growth rate over the last five years, but recent results were boosted by a one-off gain of $827.3 million. Although net profit margins have moved into positive territory, forecasts now call for earnings to drop sharply by 83.8% per year over the coming three years. Revenue is projected to rise at a slower 3.3% per year, which is behind the broader US market’s 10.5% per year expectation. With profits...

Kontoor Brands (KTB) is forecasting impressive earnings growth of 20.9% per year, outpacing the US market average of 16%. Current net profit margins have compressed to 7.7% from last year's 9.7%, and over the past five years, the company has averaged 12.4% annual earnings growth, despite recent negative momentum. With top-line growth likely but near-term margin pressure evident, investors are weighing this strong outlook against recent softness in profitability. See our full analysis for...